Humana prices $250 million add-on to 5.375% senior notes due 2031
Humana agreed on March 26, 2025 to sell an additional $250 million of its 5.375% Senior Notes due 2031, and completed the offering on March 31, 2025. The add-on brings total outstanding notes in this series to $1.5 billion, and net proceeds of about $247 million are intended for general corporate purposes, which may include repaying existing debt.
Key points
- Additional $250 million of 5.375% Senior Notes due April 15, 2031 sold at 99.941% of principal
- Total outstanding principal of the series rises to $1.5 billion from $1.25 billion
- Estimated net proceeds of approximately $247 million for general corporate purposes, which may include debt repayment
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.